Cited by 20COVID-19 epidemiological studiesCOVID-19 Clinical Research StudiesData-Driven Disease Surveillance

Excess deaths during influenza and coronavirus disease and infection-fatality rate for severe acute respiratory syndrome coronavirus 2, the netherlands

Open access
van Asten, Liselotte, Harmsen, Carel N., Stoeldraijer, Lenny, Klinkenberg, Don, Teirlinck, Anne C., de Lange, Marit M.A., Meijer, Adam, van de Kassteele, Jan +3 more·2021·Emerging infectious diseases

Abstract

Since the 2009 influenza pandemic, the Netherlands has used a weekly death monitoring system to estimate deaths in excess of expectations. We present estimates of excess deaths during the ongoing coronavirus disease (COVID-19) epidemic and 10 previous influenza epidemics. Excess deaths per influenza epidemic averaged 4,000. The estimated 9,554 excess deaths (41% in excess) during the COVID-19 epidemic weeks 12-19 of 2020 appeared comparable to the 9,373 excess deaths (18%) during the severe influenza epidemic of 2017-18. However, these deaths occurred in a shorter time, had a higher peak, and were mitigated by nonpharmaceutical control measures. Excess deaths were 1.8-fold higher than reported laboratory-confirmed COVID-19 deaths (5,449). Based on excess deaths and preliminary results from seroepidemiologic studies, we estimated the infection-fatality rate to be 1%. Monitoring of excess deaths is crucial for timely estimates of disease burden for influenza and COVID-19. Our data complement laboratory-confirmed COVID-19 death reports and enable comparisons between epidemics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid2702.202999

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [8]van Asten LW, Harmsen C, van Gageldonk C, van Pelt R, van Vliet W, van der Sande H, et al. M., Syndromic surveillance with death data: is crude mortality data suitable for real time surveillance? Advances in Disease Surveillance. 2007; 4: 269.
  2. [15]Bulletin of Influenza Surveillance. Number of ILI patients above epidemic threshold, 2020 [in Dutch] [ cited 2020 Nov 15]. https://www.nivel.nl/sites/default/files/influenza-nieuwsbrief/NB_2019_2020_no5.pdf

Cited by

Sorted by citations

Authors
van Asten, L., Harmsen, C. N., Stoeldraijer, L., Klinkenberg, D., Teirlinck, A. C., de Lange, M. M. A., Meijer, A., van de Kassteele, J., van Gageldonk-Lafeber, A. B., van den Hof, S., & van der Hoek, W.
Affiliations
National Institute for Public Health and the Environment (NL)
Venue
Emerging infectious diseases
Published
2021-02
Volume
27
Issue
2
Pages
411-420
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W3118478780
Cited by
20
References
25
Citations by year
2026: 2 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 6
FWCI
1.74
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Emerging infectious diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
  • Rivm (National Institute for Public Health and the Environment) (submittedVersion)
  • Rivm (National Institute for Public Health and the Environment) (submittedVersion, other-oa)
Topics
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Epidemiology › Data-Driven Disease Surveillance
Keywords
excess mortality, COVID-19 pandemic, SARS-CoV-2, influenza epidemic, infection fatality rate, non-pharmaceutical interventions, disease burden estimation, 2017-2018 influenza season, 2009 H1N1 pandemic, seroepidemiology, Netherlands
MeSH terms
COVID-19, SARS-CoV-2, Humans, Influenza, Human, Mortality, Netherlands, Orthomyxoviridae, Seasons, Epidemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review